The Challenge of Disease-Modifying Therapies in Parkinson’s Disease: Role of CSF Biomarkers

The development of disease modifying strategies in Parkinson’s disease (PD) largely depends on the ability to identify suitable populations after accurate diagnostic work-up. Therefore, patient molecular profiling and disease subtyping are mandatory. Thus far, in clinical trials, PD has been conside...

Descripción completa

Detalles Bibliográficos
Autores principales: Paolini Paoletti, Federico, Gaetani, Lorenzo, Parnetti, Lucilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072459/
https://www.ncbi.nlm.nih.gov/pubmed/32092971
http://dx.doi.org/10.3390/biom10020335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072459/
https://www.ncbi.nlm.nih.gov/pubmed/32092971
http://dx.doi.org/10.3390/biom10020335

Ejemplares similares